Number of items: 13.
2023
Lees, J. S. , De La Mata, N. L., Sullivan, M. K. , Wyld, M. L., Rosales, B. M., Cutting, R., Hedley, J. A., Rutherford, E., Mark, P. B. and Webster, A. C.
(2023)
Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding.
European Stroke Journal, 8(3),
pp. 756-768.
(doi: 10.1177/23969873231173282)
Mayne, K. J., Sullivan, M. K. and Lees, J. S.
(2023)
Sex and gender differences in the management of chronic kidney disease and hypertension.
Journal of Human Hypertension,
(doi: 10.1038/s41371-023-00843-9)
(Early Online Publication)
Sullivan, M. K. et al.
(2023)
Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study.
British Journal of General Practice, 73(727),
e141-e147.
(doi: 10.3399/BJGP.2022.0145)
(PMID:36376072)
(PMCID:PMC9678375)
2022
Sullivan, M. K. et al.
(2022)
The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function.
BMC Medicine, 20,
420.
(doi: 10.1186/s12916-022-02628-2)
(PMID:36320059)
(PMCID:PMC9623942)
Lees, J. S. , Rutherford, E., Stevens, K. I., Chen, D. C., Scherzer, R., Estrella, M. M., Sullivan, M. K. , Ebert, N., Mark, P. B. and Shlipak, M. G.
(2022)
Assessment of Cystatin C level for risk stratification in adults with chronic kidney disease.
JAMA Network Open, 5(10),
e2238300.
(doi: 10.1001/jamanetworkopen.2022.38300)
(PMID:36282503)
(PMCID:PMC9597396)
Sullivan, M. K. and Mark, P. B.
(2022)
Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer?
Cardiovascular Research, 118(8),
e54-e56.
(doi: 10.1093/cvr/cvac067)
(PMID:35639861)
Sullivan, M. K. et al.
(2022)
Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study.
Nephrology Dialysis Transplantation, 37(2),
pp. 271-284.
(doi: 10.1093/ndt/gfab303)
(PMID:34661677)
(PMCID:PMC8788218)
2021
Sullivan, M. K. et al.
(2021)
Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings.
BMC Medicine, 19,
278.
(doi: 10.1186/s12916-021-02147-6)
Sullivan, M. K. et al.
(2021)
Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort.
Clinical Kidney Journal, 14(11),
pp. 2409-2419.
(doi: 10.1093/ckj/sfab079)
(PMCID:PMC8573008)
Lees, J. S. et al.
(2021)
Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study.
EClinicalMedicine, 38,
101030.
(doi: 10.1016/j.eclinm.2021.101030)
(PMID:34505030)
Drake, T. M. et al.
(2021)
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
Lancet, 398(10296),
pp. 223-237.
(doi: 10.1016/S0140-6736(21)00799-6)
(PMID:34274064)
(PMCID:PMC8285118)
2020
McQueenie, R. et al.
(2020)
Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
PLoS ONE, 15(8),
e0238091.
(doi: 10.1371/journal.pone.0238091)
(PMID:32817712)
(PMCID:PMC7440632)
Sullivan, M. , Rankin, A. , Jani, B. D. , Mair, F. S. and Mark, P. B.
(2020)
Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
BMJ Open, 10,
e038401.
(doi: 10.1136/bmjopen-2020-038401)
(PMID:32606067)
(PMCID:PMC7328898)
This list was generated on Mon Sep 25 14:44:05 2023 BST.